Amprolium
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101633This classification denotes an antiparasitic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 95CO6N199Q. European Medicines Agency schedules Amprolium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05489MIG. Amprolium generally arises in the molecular formula C14H19CLN4. The term AMPROLIUM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 no. 12 1967, list 7.) AMPROLIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amprolium under HS 29335995 and SITC 51576. As of Q4 2014, AMPROLIUM remains the US FDA Preferred Term for this commodity. Amprolium bears US NLM identifiers UMLS ID C0002686 and NCI Concept Code C76388. SMILES: [N]1(CC2C(NC(NC2)CCC)N)C(CCCC1)C.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.